Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30- and 90-Days Following Hospital Discharge
News | Heart Failure
New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin’s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart Failure

November 9, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3 ...

Home November 09, 2022
Home
Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30- and 90-Days Following Hospital Discharge
News | Hypertension
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions

November 9, 2022 — CinCor Pharma, Inc. announced the presentation today of Phase 2 data from its BrigHtn trial as part ...

Home November 09, 2022
Home
GettyImages-523520100
Feature | Angiography | By Bhvita Jani
Interventional X-ray and Mobile C-arm Equipment Markets Had a Double-digit Recovery in 2021

The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026 ...

Home November 09, 2022
Home
AHA 2022 Kevin-Volpp-headshot-768x794
Feature | AHA
American Heart Association Honors Distinguished Scientists at AHA22

November 9, 2022 — Seven awardees were honored during the American Heart Association Scientific Sessions (AHA 2022). The ...

Home November 09, 2022
Home
Tech tools are creating positive change in Cardiac MRI Software Market
Feature | Magnetic Resonance Imaging (MRI) | By Christine Book
AI-powered Software Solutions Enhance Cardiac Diagnostics

Interventional cardiologists know well the phrase “change is the only constant.” This is especially relevant as ...

Home November 09, 2022
Home
Artificial intelligence-powered alternative data is driving novel and disruptive market research opportunities at a staggering clip amid category growth forecasts, prompting industries of every size and sort to capitalize on this strategy that’s ever evolving and innovating 
Feature | Cardiovascular Business | By Merilee Kern, MBA
AI-Powered Alternative Data Driving Extreme Market Research Disruption

Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...

Home November 09, 2022
Home
In 2023, the DAIC/dicardiology.com team looks to enhance its educational offerings to build the resources you need and have been asking for.
Blog | Cardiovascular Business
Enhancing the Educational Experience

Reflecting back, 2022 has been a productive year. It brought with it many changes and challenges, but also brought back ...

Home November 09, 2022
Home
New genomic therapies for cardiovascular disease are reaching the clinical trial stage, according to moderators of a session presented at the American Heart Association Annual Scientific Session (AHA2022).
News | AHA
Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022

November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be ...

Home November 08, 2022
Home
Robert J. Mentz, M.D., Associate Professor of Medicine, Chief, Heart Failure Section, Associate Program Director, Duke Cardiology Fellowship, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, image copyright Robert J. Mentz
News | AHA
TRANSFORM-HF Trial Found No Difference in Effectiveness Between 2 Common Loop Diuretics

November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication ...

Home November 08, 2022
Home
Julian D. Gillmore, M.D., Ph.D., Professor, University College London Centre for Amyloidosis, United Kingdom, image copyright University College London Centre for Amyloidosis
News | AHA
Novel Gene-Editing Therapy Shows Promise For Patients With Transthyretin Amyloid Cardiomyopathy

November 8, 2022 — A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly ...

Home November 08, 2022
Home
Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio suite of products across a range of clinical applications
News | AHA
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

Home November 08, 2022
Home
Cardio StillShot enables 6x higher temporal resolution compared to conventional image reconstruction methods by detecting and correcting motion in the heart
News | Computed Tomography (CT)
Fujifilm Introduces Scenaria View Focus Edition CT Scanner with Cardio StillShot, a new Cardiac Motion Correction Feature

November 8, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Home November 08, 2022
Home
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment
News | AHA
Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing

November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial results ...

Home November 07, 2022
Home
A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective
News | AHA
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective

November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

Home November 07, 2022
Home
Petr Ostadal, M.D., Ph.D., Professor of Medicine, Department of Cardiology, Na Homolce Hospital, Czech Republic. Image copyright Na Homolce Hospital
News | AHA
Early Use of ECMO devices Did Not Improve Outcomes in People With Cardiogenic Shock

November 7, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) ...

Home November 07, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now